» Authors » Konstantinos C Fragkos

Konstantinos C Fragkos

Explore the profile of Konstantinos C Fragkos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 422
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fragkos K
MedEdPublish (2016) . 2023 Dec; 7:67. PMID: 38089214
This article was migrated. The article was marked as recommended. The present essay describes a model under which a method of self-improvement of teacher-educator practice can be implemented by analyzing...
2.
Inniss S, Fragkos K, Whitley L, Wimpory R, Rebello E, Lisboa A, et al.
Ther Adv Chronic Dis . 2023 Aug; 14:20406223231189072. PMID: 37601038
Background: Ustekinumab was approved in 2016 for the treatment of moderate-severe Crohn's disease (CD). Clinical trials and real-world studies have suggested ustekinumab to be a safe and effective treatment; however,...
3.
Gompelman M, Wezendonk G, Wouters Y, Beurskens-Meijerink J, Fragkos K, Rahman F, et al.
Clin Nutr . 2023 Mar; 42(5):706-716. PMID: 36965196
Background & Aims: Staphylococcus aureus decolonization has proven successful in prevention of S. aureus infections and is a key strategy to maintain venous access and avoid hospitalization in patients receiving...
4.
Keane N, Ghannam A, Fragkos K, Rahman F
Clin Nutr ESPEN . 2022 Oct; 51:174-184. PMID: 36184202
Background & Aims: Scleroderma is a multi-system disease that causes hardening of connective tissue. The gastrointestinal (GI) tract is affected in 90% of patients, which may cause nutritional decline. Due...
5.
McLeese R, Spinou A, Alfahl Z, Tsagris M, Elborn J, Chalmers J, et al.
Eur Respir J . 2021 Apr; 58(5). PMID: 33888521
Introduction: Understanding the psychometric properties of health-related quality of life (HRQoL) questionnaires can help inform selection in clinical trials. Our objective was to assess the psychometric properties of HRQoL questionnaires...
6.
Plyta M, Patel P, Fragkos K, Kumagai T, Mehta S, Rahman F, et al.
Nutrients . 2020 Aug; 12(8). PMID: 32784602
(1) Background: Malnutrition in cancer patients impacts quality of life (QoL) and performance status (PS). When oral/enteral nutrition is not possible and patients develop intestinal failure, parenteral nutrition (PN) is...
7.
Fragkos K, Picasso Bouroncle M, Kumar S, Caselton L, Menys A, Bainbridge A, et al.
Nutrients . 2020 Jul; 12(7). PMID: 32707726
(1) Background: Intestinal failure-associated liver disease (IFALD) in adults is characterized by steatosis with variable progression to fibrosis/cirrhosis. Reference standard liver biopsy is not feasible for all patients, but non-invasive...
8.
OHanlon F, Fragkos K, Fini L, Patel P, Mehta S, Rahman F, et al.
Nutr Cancer . 2020 Jun; 73(6):943-955. PMID: 32586120
The use of home parenteral nutrition (HPN) in patients with incurable cancer remains controversial with significant variation worldwide. We aimed to systematically evaluate the literature from 1960 to 2018 examining...
9.
Patel P, Fragkos K, Keane N, Cauldwell K, OHanlon F, ROGERs J, et al.
Nutr Cancer . 2020 May; 73(4):572-587. PMID: 32434435
We describe a retrospective cohort study of patients with malignant bowel obstruction to examine their nutritional care pathways between 1.1.16 and 31.12.16 with readmissions until 31.12.17. Data were analyzed by...
10.
Fragkos K, Thong D, Cheung K, Thomson H, Windsor A, Engledow A, et al.
Nutrition . 2020 Mar; 73:110722. PMID: 32169549
Objectives: The management of enterocutaneous fistulae (ECF) is complex, challenging, and often associated with metabolic, septic, and nutritional complications. Radiographic quantification of body composition such as fat or lean body...